Trials / Completed
CompletedNCT00783354
A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)
A Pilot, Multicenter, Double-blind Randomized Study for Comparison of Aerius® "Continuous Treatment" Versus Aerius® "PRN Regimen" on Chronic Idiopathic Urticaria Patient Quality of Life
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 129 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This double-blind pilot study was conducted to establish the best way of using desloratadine treatment to protect quality of life of chronic idiopathic urticaria (CIU) patients, after an initial 4-weeks of daily treatment: prolonging systematic daily treatment or as needed (PRN; in the case of symptoms).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | desloratadine | Patients received desloratadine 5 mg daily, given as one tablet in the evening, and were asked to take one tablet of "rescue medication" (Placebo) in case of symptoms for 2 months. |
| DRUG | desloratadine | Patients received Placebo daily, given as one tablet in the evening, and were asked to take one tablet of "rescue medication" (desloratadine 5 mg) in case of symptoms for 2 months. |
Timeline
- Start date
- 2003-04-01
- Primary completion
- 2004-02-01
- Completion
- 2004-04-01
- First posted
- 2008-10-31
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00783354. Inclusion in this directory is not an endorsement.